NO20091675L - Eterderivatbaserte dobbeltvirkende modulatorer pa 5-HT2A og D3 receptorer - Google Patents
Eterderivatbaserte dobbeltvirkende modulatorer pa 5-HT2A og D3 receptorerInfo
- Publication number
- NO20091675L NO20091675L NO20091675A NO20091675A NO20091675L NO 20091675 L NO20091675 L NO 20091675L NO 20091675 A NO20091675 A NO 20091675A NO 20091675 A NO20091675 A NO 20091675A NO 20091675 L NO20091675 L NO 20091675L
- Authority
- NO
- Norway
- Prior art keywords
- ht2a
- receptors
- drug
- ether derivative
- based double
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06123274 | 2006-10-31 | ||
PCT/EP2007/061253 WO2008052899A1 (en) | 2006-10-31 | 2007-10-22 | Ether derivatives dual modulators of the 5-ht2a and d3 receptors |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20091675L true NO20091675L (no) | 2009-05-28 |
Family
ID=38962066
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20091675A NO20091675L (no) | 2006-10-31 | 2009-04-28 | Eterderivatbaserte dobbeltvirkende modulatorer pa 5-HT2A og D3 receptorer |
Country Status (18)
Country | Link |
---|---|
US (1) | US7795437B2 (zh) |
EP (1) | EP2079693B1 (zh) |
JP (1) | JP5087631B2 (zh) |
KR (1) | KR101114651B1 (zh) |
CN (1) | CN101535258B (zh) |
AR (1) | AR063438A1 (zh) |
AU (1) | AU2007316249B2 (zh) |
BR (1) | BRPI0718127A2 (zh) |
CA (1) | CA2667511A1 (zh) |
CL (1) | CL2007003110A1 (zh) |
ES (1) | ES2401663T3 (zh) |
IL (1) | IL198157A0 (zh) |
MX (1) | MX2009004615A (zh) |
NO (1) | NO20091675L (zh) |
PE (1) | PE20081342A1 (zh) |
RU (1) | RU2009116509A (zh) |
TW (1) | TW200826940A (zh) |
WO (1) | WO2008052899A1 (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5502733B2 (ja) * | 2007-07-26 | 2014-05-28 | エフ.ホフマン−ラ ロシュ アーゲー | 5−ht2a及びd3受容体の二重のモジュレーター |
US8273900B2 (en) | 2008-08-07 | 2012-09-25 | Novartis Ag | Organic compounds |
WO2011060363A2 (en) * | 2009-11-16 | 2011-05-19 | Auspex Pharmaceuticals, Inc. | Cyclohexyl urea modulators of d2 receptors and/or d3 receptors |
US8877778B2 (en) | 2010-12-15 | 2014-11-04 | Hoffmann-La Roche Inc. | Benzofurane compounds |
US8722683B2 (en) * | 2011-02-17 | 2014-05-13 | Hoffmann La-Roche Inc. | Benzodioxole piperazine compounds |
US8921397B2 (en) | 2011-05-04 | 2014-12-30 | Hoffmann-La Roche Inc. | Benzofurane-piperidine compounds |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4024264A (en) * | 1974-08-15 | 1977-05-17 | Ab Ferrosan | Diphenylbutylpiperidines |
GB1514718A (en) | 1974-08-15 | 1978-06-21 | Ferrosan Ab | Diphenyl-butylpiperidines |
JP2860689B2 (ja) | 1990-03-14 | 1999-02-24 | 第一製薬株式会社 | ピリミジン誘導体 |
EP0479601B1 (en) | 1990-10-05 | 1999-12-15 | Ajinomoto Co., Inc. | Piperidine derivatives and their use as antiarrhythmic agents |
US6518286B1 (en) | 1999-03-26 | 2003-02-11 | Astrazeneca Ab | Compounds |
HU227543B1 (en) * | 2001-09-28 | 2011-08-29 | Richter Gedeon Nyrt | N-[4-(2-piperazin- and 2-piperidin-1-yl-ethyl)-cyclohexyl]-sulfon- and sulfamides, process for their preparation, their use and pharmaceutical compositions containing them |
HUP0103986A2 (hu) | 2001-09-28 | 2003-06-28 | Richter Gedeon Vegyészeti Gyár Rt. | Új karbonsavamid szerkezetet tartalmazó piperidinil vegyületek, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények |
ES2254772T3 (es) | 2001-12-04 | 2006-06-16 | Actelion Pharmaceuticals Ltd. | 4-(piperidil-y pirrolidil-alquil-ureido)-quinoleinas como receptores antagonistas de urotensina ii. |
EP1348434A1 (en) | 2002-03-27 | 2003-10-01 | Fujisawa Deutschland GmbH | Use of pyridyl amides as inhibitors of angiogenesis |
AU2003303678A1 (en) | 2003-01-03 | 2004-08-10 | Genzyme Corporation | Urea derivatives and their use as anti-inflammatory agents |
HU227534B1 (en) | 2003-08-04 | 2011-08-29 | Richter Gedeon Nyrt | (thio)carbamoyl-cyclohexane derivatives, process for producing them and pharmaceutical compositions containing them |
-
2007
- 2007-10-22 US US11/876,007 patent/US7795437B2/en not_active Expired - Fee Related
- 2007-10-22 KR KR1020097008855A patent/KR101114651B1/ko not_active IP Right Cessation
- 2007-10-22 MX MX2009004615A patent/MX2009004615A/es active IP Right Grant
- 2007-10-22 JP JP2009535053A patent/JP5087631B2/ja not_active Expired - Fee Related
- 2007-10-22 CN CN2007800408979A patent/CN101535258B/zh not_active Expired - Fee Related
- 2007-10-22 WO PCT/EP2007/061253 patent/WO2008052899A1/en active Application Filing
- 2007-10-22 BR BRPI0718127-2A2A patent/BRPI0718127A2/pt not_active IP Right Cessation
- 2007-10-22 CA CA002667511A patent/CA2667511A1/en not_active Abandoned
- 2007-10-22 ES ES07821617T patent/ES2401663T3/es active Active
- 2007-10-22 AU AU2007316249A patent/AU2007316249B2/en not_active Expired - Fee Related
- 2007-10-22 EP EP07821617A patent/EP2079693B1/en not_active Not-in-force
- 2007-10-22 RU RU2009116509/04A patent/RU2009116509A/ru unknown
- 2007-10-29 AR ARP070104779A patent/AR063438A1/es unknown
- 2007-10-29 CL CL200703110A patent/CL2007003110A1/es unknown
- 2007-10-29 TW TW096140627A patent/TW200826940A/zh unknown
- 2007-10-31 PE PE2007001497A patent/PE20081342A1/es not_active Application Discontinuation
-
2009
- 2009-04-16 IL IL198157A patent/IL198157A0/en unknown
- 2009-04-28 NO NO20091675A patent/NO20091675L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
RU2009116509A (ru) | 2010-12-10 |
MX2009004615A (es) | 2009-05-22 |
TW200826940A (en) | 2008-07-01 |
KR101114651B1 (ko) | 2012-06-12 |
KR20090075848A (ko) | 2009-07-09 |
WO2008052899A1 (en) | 2008-05-08 |
EP2079693B1 (en) | 2013-02-27 |
AU2007316249B2 (en) | 2013-01-24 |
ES2401663T3 (es) | 2013-04-23 |
CN101535258A (zh) | 2009-09-16 |
US7795437B2 (en) | 2010-09-14 |
CN101535258B (zh) | 2012-12-05 |
US20080103174A1 (en) | 2008-05-01 |
PE20081342A1 (es) | 2008-09-18 |
CL2007003110A1 (es) | 2008-06-13 |
JP5087631B2 (ja) | 2012-12-05 |
AU2007316249A1 (en) | 2008-05-08 |
CA2667511A1 (en) | 2008-05-08 |
JP2010508319A (ja) | 2010-03-18 |
BRPI0718127A2 (pt) | 2014-02-18 |
IL198157A0 (en) | 2009-12-24 |
AR063438A1 (es) | 2009-01-28 |
EP2079693A1 (en) | 2009-07-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20090166L (no) | Amino-imidazoloner og deres anvendelse som et medikament for behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerering og demens | |
WO2009013212A3 (en) | Dual modulators of 5-ht2a and d3 receptors | |
NO20091675L (no) | Eterderivatbaserte dobbeltvirkende modulatorer pa 5-HT2A og D3 receptorer | |
NO20090755L (no) | Amino-imidazoloner og deres anvendelse som et medikament for behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerering og demens | |
NO20083197L (no) | Substituert cinnolin-derivater som GABAA-reseptor modulatorer og metode for deres syntese | |
TW200718692A (en) | Dihydrobenzofuran derivatives and uses thereof | |
MX2007013021A (es) | Derivados de benzofuranil-alcanamina y usos de los mismos como agonistas de 5-ht2c. | |
NO20081476L (no) | Substituerte benzimidazoler og fremgangsmater for fremstilling | |
TW200720266A (en) | Benzodioxane and benzodioxolan derivatives and uses thereof | |
NO343929B3 (no) | 1-[2-(2,4-dimetylfenylsulfanyl-fenyl]-piperazin som en forbindelse med kombinert serotoninreopptak, 5-HT3- og 5HT1A-aktivitet for behandlingen av kognitiv smerte | |
WO2009123714A3 (en) | Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor | |
WO2009100936A3 (de) | Neue aromatische fluorglykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung | |
ATE523510T1 (de) | Substituierte 4-aryl-1,4-dihydro-1,6- naphthyridine und ihre verwendung | |
WO2009065922A3 (de) | Organische verbindungen | |
NO20063602L (no) | Benzyl(iden)-laktam-derivater | |
WO2010102778A3 (de) | Substituierte 3-aminoisoxazolopyridine als kcnq2/3 modulatoren | |
MX2011008336A (es) | Derivados de dihidroquinolinona. | |
NO20091782L (no) | Fremgangsmate for syntese av derivater av 3-amino-tetrahydrofuran-3-karboxylsyre og deres anvendelse som medikamenter | |
WO2007150010A3 (en) | Cyclopropyl amine derivatives as histamin h3 receptor modulators | |
MX2010001195A (es) | Derivados de benzoil-peperidina como moduladores dobles de los receptores 5-ht2a y d3. | |
ECSP10010606A (es) | Derivados de quinuclidina como antagonistas de receptores muscarinicos m3 | |
ATE524451T1 (de) | Substituierte n-benzo ädü isoxazol-3-yl-amin- derivative als inhibitoren von mglur5, serotonin- (5-ht) und noradrenalin rezeptoren und deren verwendung zur herstellung von arzneimitteln | |
ATE495159T1 (de) | Diaminocyclohexan- und diaminocyclopentanderivate | |
ATE443707T1 (de) | Isoxazolin-indol-derivate mit verbesserter antipsychotischer und anxiolytischer aktivität | |
NO20092400L (no) | 4-(Heterocyclyl)Alkyl-N-(Arylsulfonyl) indole compounds and their use as 5-HT6 Ligands |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |